Shandong Jincheng Pharmaceutical Group Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jiaquan Li
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.8yrs |
| CEO ownership | 0.3% |
| Management average tenure | 1.9yrs |
| Board average tenure | 4.6yrs |
Recent management updates
Recent updates
Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Bounce 39% But Its Business Still Trails The Market
Oct 08
Estimating The Intrinsic Value Of Shandong Jincheng Pharmaceutical Group Co., Ltd (SZSE:300233)
Oct 07Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Popularity With Investors Is Under Threat From Overpricing
Jun 07Shandong Jincheng Pharmaceutical Group's (SZSE:300233) Problems Go Beyond Weak Profit
Apr 04Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Climb 29% But Its Business Is Yet to Catch Up
Mar 04Shandong Jincheng Pharmaceutical Group (SZSE:300233) Seems To Use Debt Quite Sensibly
Mar 02CEO
Jiaquan Li (52 yo)
13.8yrs
Tenure
CN¥1,799,000
Compensation
Mr. Jiaquan Li serves as Vice Chairman at Shandong Jincheng Pharmaceutical Group Co., Ltd. He has been Director at Shandong Jincheng Pharmaceutical Group Co., Ltd. since May 16, 2011 and also serves as its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Vice Chairman | no data | CN¥1.80m | 0.27% CN¥ 13.3m | |
| Financial Director | 1.7yrs | CN¥677.00k | no data | |
| VP & Secretary of the Board of Directors | 13.8yrs | CN¥995.00k | 0.085% CN¥ 4.2m | |
| VP & Director | no data | CN¥1.20m | 0.047% CN¥ 2.3m | |
| Vice President | 1.9yrs | CN¥1.19m | 0.014% CN¥ 697.9k |
1.9yrs
Average Tenure
48yo
Average Age
Experienced Management: 300233's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Vice Chairman | 13.8yrs | CN¥1.80m | 0.27% CN¥ 13.3m | |
| VP & Director | no data | CN¥1.20m | 0.047% CN¥ 2.3m | |
| Chairman | 13.8yrs | CN¥2.00m | 1.91% CN¥ 93.4m | |
| Employee Representative of the Supervisory Board | 10.8yrs | no data | no data | |
| Independent Director | 4.6yrs | CN¥77.90k | no data | |
| Independent Director | 4.6yrs | CN¥77.90k | no data | |
| Chairman of the Supervisory Board | 4.6yrs | no data | no data | |
| Independent Director | 1.7yrs | CN¥60.00k | no data | |
| Non-Independent Director | 1.7yrs | CN¥337.00k | 0.0047% CN¥ 232.8k | |
| Supervisor | 1.7yrs | no data | no data |
4.6yrs
Average Tenure
48.5yo
Average Age
Experienced Board: 300233's board of directors are considered experienced (4.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 13:28 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shandong Jincheng Pharmaceutical Group Co., Ltd is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yalei Yan | Bohai Securities Co., Ltd. |
| YANG QIAO | Changjiang Securities Co. LTD. |
| Chong Chen | Founder Securities Co., Ltd. |